- 2 days ago
Tome Biosciences' CEO on the company's 'Programmable Genomic Integration' platform and NHP data presented at #ASGCT2024
- 3 days ago
In humanized mouse models, Tessera is demonstrating LNP delivery of gene writers to, and rewriting of, hematopoietic stem cells to an extent that could be curative in sickle cell disease
- 3 days ago
Ring Therapeutics believes that the next great viral vector is a ubiquitous, but little known, family of viruses already found in the body
- 3 days ago
ProQR's CEO at #ASGCT2024 on NHP proof-of-concept data for the company's Axiomer RNA-editing platform
- 3 days ago
Ascidian presented NHP and human retinal explant data at #ASGCT2024 suggesting proof of concept for its RNA exon editing approach
- 3 days ago
Attovia Therapeutics raised a $105M series B today to take on the I&I space, including designing multi-target bispecifics